product description page
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy (Hardcover)
about this item
This volume focuses on the recent advances in understanding T cells are key players in antitumor immune responses and T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.
The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.
Genre: Medical, Science
Series Title: Resistance to Targeted Anti-cancer Therapeutics
Publisher: Springer Verlag
Street Date: October 2, 2016
Item Number (DPCI): 248-23-6564